Medford, MA · Founded 2021 · Privately Held (backing)
Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases. Unravel Biosciences is based in Medford, MA and was founded in 2021. It was valued at $18 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $4.5 million across 2 recorded rounds; the latest was a $500,000 seed round in Feb 2023.
PMV mark · valuation
$18.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$4.5M
Last round
Seed Round
Feb 2023
No prints on record
No secondary trades in Unravel Biosciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Unravel Biosciences with a free account
·The complete investor list: 12 names
·Watch Unravel Biosciences: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Unravel Biosciences stock.
